At Blossom Family Medicine, we love helping you connect the dots between your bodys systems
When two substances that both influence the nervous system are used together, they can amplify certain effects
The medical evaluation includes: Review of your health history, including current medications, medical conditions, allergies, and previous weight loss attempts Assessment of your eligibility for GLP-1 therapy based on BMI, health conditions, and contraindications Discussion of treatment options, expected outcomes, potential side effects, and risks Determination of the appropriate medication (semaglutide or tirzepatide), starting dose, and titration schedule A prescription written by a licensed healthcare provider (physician, nurse practitioner, or physician assistant) who has determined that GLP-1 therapy is medically appropriate for you This evaluation can occur in-person with your primary care provider or specialist, or via a telehealth platform like FormBlends
On the other hand, GIP-producing K-cells were devoid of GHS-R1a (data not shown)
PT-141 and Melanotan II both act on the melanocortin receptor family, and combining two melanocortin agonists has not been studied for safety
Abnormal insulin secretion in Parkinsons disease before and during L-dihydroxyphenylalanine (L-dopa) therapy
